{{Rsnum
|rsid=17067123
|Chromosome=4
|position=179127208
|Orientation=plus
|GMAF=0.2213
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 79.5 | 18.8 | 1.8
| HCB | 35.6 | 46.7 | 17.8
| JPT | 38.7 | 39.6 | 21.6
| YRI | 73.1 | 24.1 | 2.8
| ASW | 61.4 | 33.3 | 5.3
| CHB | 35.6 | 46.7 | 17.8
| CHD | 27.1 | 49.5 | 23.4
| GIH | 56.0 | 38.0 | 6.0
| LWK | 67.3 | 27.1 | 5.6
| MEX | 39.7 | 44.8 | 15.5
| MKK | 73.5 | 21.9 | 4.5
| TSI | 81.4 | 17.6 | 1.0
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19684573
|Trait=Response to Hepatitis C treatment
|Title=Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
|RiskAllele=
|Pval=0.000008
|OR=NR
|ORtxt=NR
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs17067123
|overall_frequency_n=27
|overall_frequency_d=128
|overall_frequency=0.210938
|n_genomes=19
|n_genomes_annotated=0
|n_haplomes=20
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}